Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Interest Coverage Ratio of 25.04 for Q2 2026, down 144.96% year-over-year from 55.69 in Q2 2025, and down 9267.46% on a QoQ basis from 0.27 in Q4 2025.
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Interest Coverage Ratio for 16 years, with the latest figure at 25.04 in Q2 2026.
- Interest Coverage Ratio for Q2 2026 came in at 25.04, down 144.96% year-over-year; the trailing twelve-month figure through Jun 2026 was 26.76 (down 90.9% YoY), and the FY2025 annual result was 0.11, down 108.62% from the prior year.
- Interest Coverage Ratio declined to 25.04 in Q2 2026, from 0.27 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 381.73 in Q3 2024 and troughed at 1309.37 in Q3 2025.
- A 5-year average of 52.57 and a median of 0.09 in 2022 frame the typical range for Interest Coverage Ratio.
- The widest annual swing landed in 2023, when Interest Coverage Ratio plunged 12858.2%; it then surged 7231.56% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 21.54 in 2022, then sank by 75.83% to 5.21 in 2023, then slumped by 131.09% to 1.62 in 2024, then surged by 116.87% to 0.27 in 2025, then plunged by 9267.46% to 25.04 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 25.04 in Q2 2026, 0.27 in Q4 2025, and 1309.37 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | -25.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.04 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | -1,309.37 |
| Jun 30, 2025 | 55.69 |
| Mar 31, 2025 | -2.64 |
| Dec 31, 2024 | 5.27 |
| Sep 30, 2024 | 381.73 |
| Jun 30, 2024 | 5.46 |
| Mar 31, 2024 | -0.79 |
| Dec 31, 2023 | -2.12 |
| Jun 30, 2023 | -19.33 |
| Mar 31, 2023 | 1.50 |
| Dec 31, 2022 | 3.31 |
| Sep 30, 2022 | 1.23 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 1.03 |
| Sep 30, 2021 | 5.50 |
| Jun 30, 2021 | 6.24 |
| Mar 31, 2021 | 2.17 |